Reveal all classes of structural variants using Bionano’s optical genome mapping Stratys™ System. Explore the Stratysphere!

Join us for the first webinar in our newest 6-part Bionano In-Motion series, featuring Dr. Guilin Tang from MD Anderson Cancer Center. Dr. Tang will explore the MD Anderson team’s groundbreaking study published in the American Journal of Hematology, highlighting the potential of optical genome mapping (OGM) in detecting structural variants linked to chromoanagenesis (CAG) in acute myeloid leukemia (AML). Performed on a prospectively collected cohort of 410 AML cases, this is the biggest AML study published to date. Don’t miss this opportunity to engage with Dr. Tang on her latest findings! Register here to reserve your spot.